Vikram Gupta sold $33k of SYNA
See Remarks at SYNAPTICS Inc. 412 shares at an average of $80.17, traded Nov 27, 2024, filed Dec 2, 2024.
Score components
- +15RoleOfficer
- +6Trade size$33k at market
- 0Share of holdings soldSold 1.0% of holdings
- 0ClusterNo other insider selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-24-132279, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 27, 2024 | SOpen-market sale Common Stock10b5-1 | -412 | $80.17 | $33k | 41,206 | Dec 2, 2024 |
Related signals
Other insiders at SYNAPTICS Inc and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 10Weak | SYNAPTICS Inc | Esther Song See Remarks | $15k 147 shares | -1% | |
| 22Weak | SYNAPTICS Inc | Rahul G. Patel See remarks below | $214k 2,276 shares | -1% | |
| 15Weak | SYNAPTICS Inc | Lisa Bodensteiner See Remarks | $31k 334 shares | -0% | |
| 10Weak | SYNAPTICS Inc | Esther Song See Remarks | $5,836 63 shares | -0% | |
| 1Weak | SYNAPTICS Inc | Vikram Gupta See Remarks | $34k 411 shares | -1% | |
| 1Weak | SYNAPTICS Inc | Vikram Gupta See Remarks | $33k 411 shares | -1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.